Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2001 Mar 13;14(6):330–335. doi: 10.1002/1098-2825(20001212)14:6<330::AID-JCLA14>3.0.CO;2-P

Biochemical and ultrastructural features of human milk and nipple aspirate fluids

Manuela Malatesta 1, Ferdinando Mannello 1,✉, Giuseppe Bianchi 2, Maurizio Sebastiani 3, Giancarlo Gazzanelli 1
PMCID: PMC6807916  PMID: 11138618

Abstract

Breast duct epithelium produces, secretes, and metabolises several biologically important compounds, which are found in breast secretions obtained in physiologic and pathologic conditions (milk and nipple aspirate fluids, respectively). In order to preliminarily evaluate the ultrastructural morphology of the cells found in Type II nipple aspirate fluids (NAF) and correlate it with the biochemical profile of the extracellular fluid present in these breast secretions and in human milk, we analyzed 72 NAFs from nonlactating premenopausal women affected by various breast diseases and 10 normal milk samples. Although several constitutive proteins were detected in all samples examined, the preliminary biochemical analyses and electrophoretic profiles revealed characteristic behaviours for several biologic constituents, suggesting a possible basic mechanism of production by breast epithelial cells during both physiologic and pathologic conditions. The ultrastructural analysis of milk cellular components give preliminary evidence of the apocrine secretion mechanism peculiar of breast gland, whereas Type II NAF cells appeared as biosynthetically active cells, showing a possible modified secretion mechanism. Our multidisciplinary approach seems to support the hypothesis that cellular and biochemical behaviour of Type II NAF may be an useful tool to identify aberrated breast epithelial cells in nonlactating women that might be prone to premalignant transformation. J. Clin. Lab. Anal. 14:330–335, 2000. © 2000 Wiley‐Liss, Inc.

Keywords: biochemistry, breast secretion, electron microscopy, milk, nipple

REFERENCES

  • 1. Sauter ER, Ross E, Daly M, Klein‐Szanto A, Engstrom PF, Sorling A. 1997. Nipple aspirate fluid: a promising non‐invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76:494–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Petrakis NL. 1994. Nipple aspirate fluids in studies of breast disease In: Srivastava S, Lippman SM, Hong WK, Mulshine JL, editors. Early detection of cancer: molecular markers. Armonk, NW: Futura Publishing Co. p 217–225. [Google Scholar]
  • 3. Petrakis NL. 1993. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev 2:3–10. [PubMed] [Google Scholar]
  • 4. Haagensen CD. 1990. Diseases of the breast. Philadelphia: W.B. Saunders & Co. [Google Scholar]
  • 5. Sánchez LM, Vizoso F, Díez‐Itza I, López‐Otín C. 1992. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 52:95–100. [PubMed] [Google Scholar]
  • 6. Petrakis NL. 1986. Physiologic, biochemical and cytologic aspects of nipple aspirate fluid. Breast Cancer Res Treat 8:7–19. [DOI] [PubMed] [Google Scholar]
  • 7. Petrakis NL, Lim ML, Miike R, Lee RE, Morris M, Lee L, Mason L. 1989. Nipple aspirate fluids in adult nonlactating women: lactose content, cationic Na, K, and Na/K ratio, and coloration. Breast Cancer Res Treat 13:71–78. [DOI] [PubMed] [Google Scholar]
  • 8. Sauter ER, Ehya H, Babb J, Diamandis EP, Daly M, Klein‐Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF. 1999. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer 81:1222–1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Mannello F, Malatesta M, Sebastiani M, Gazzanelli G. 1999. Molecular forms and ultrastructural localization of prostate‐specific antigen in nipple aspirate fluids. Clin Chem 45:2263–2266. [PubMed] [Google Scholar]
  • 10. Malatesta M, Mannello F, Sebastiani M, Cardinali A, Marcheggiani F, Gazzanelli G. 1998. Ultrastructural characterization and biochemical profile of human gross cystic breast disease. Breast Cancer Res Treat 48:211–219. [DOI] [PubMed] [Google Scholar]
  • 11. Mannello F, Troccoli R. 1992. Improved electrophoretic map of breast cyst fluid proteins. Cancer Detect Prev 16:107–112. [PubMed] [Google Scholar]
  • 12. Rose DP. 1993. Hormones and growth factors in nipple aspirates from normal women and benign breast disease patients. Cancer Detect Prev 16:45–51. [PubMed] [Google Scholar]
  • 13. Sartorius OW. 1995. The biochemistry of breast cyst fluids and duct secretions. Breast Cancer Res Treat 35:255–266. [DOI] [PubMed] [Google Scholar]
  • 14. Vizoso F, Sánchez LM, Díez‐Itza I, Tuya AF, Ruibal A, López‐Otín C. 1994. Relationship between serum prolactin levels and protein composition of breast secretions in nonlactating women. J Clin Endocrinol Metab 79:525–529. [DOI] [PubMed] [Google Scholar]
  • 15. Schultz GS, Ebner KE. 1977. α‐Lactalbumin levels in human mammary tumors, sera, and mammary cell culture lines. Cancer Res 37:4489–4492. [PubMed] [Google Scholar]
  • 16. Osborne CK, Arteaga CL. 1990. Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Treat 15:3–11. [DOI] [PubMed] [Google Scholar]
  • 17. Schwarzacher HG, Wachtler F. 1993. The nucleolus. Anat Embryol 188:515–536. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES